Vijay Kuchroo, DVM, PhD, of the Department of Neurology, received the BioLegend William E. Paul Award from the International Cytokine and Interferon Society (ICIS) for advancing understanding of the cytokine interleukin17 (IL-17) in health and disease. This award recognizes leading biomedical scientists who have made substantial contributions to research on cytokines, small proteins instrumental in immune activity.
Kuchroo shares the award with Sarah Gaffen, PhD, of the Pittsburg School of Medicine. The two researchers have conducted groundbreaking work characterizing the T cells that produce IL-17 and demonstrating the role of the protein in inflammation and autoimmunity. Kuchroo’s work has helped advance the development of immune therapies that target the Tim-3 checkpoint in cancers and IL-17 in autoimmune diseases. Many of the tools developed by his laboratory have propelled research on multiple sclerosis.
The ICIS is a nonprofit organization of over 1,050 scientists from across different research disciplines who are dedicated to promoting treatments for autoimmune diseases, cancer, infectious diseases and inflammation through the field of cytokine biology. BioLegend, an antibody and reagent manufacturer, sponsors the award.